[Streptococcus agalactiae late-onset neonatal infections in Barcelona (1996-2010)].
OBJECTIVE
To study the characteristics and evolution of group B Streptococcus (GBS) late-onset diseases, over a period of 15years in 8hospitals the Barcelona area and analyze the possible impact of prophylactic measures for the prevention of early-onset neonatal infections.


METHODS
Retrospective review of all patients diagnosed with late-onset neonatal disease due to GBS from 1996 to 2010.


RESULTS
A total of 143 patients were diagnosed. Of these, 51 were born in others hospitals. The overalll incidence was 0.42 per 1000 live births, varying between 0.14‰ in the year 2000 and 0.80‰ in 2009. A slight but sustained tendency of increased risk was observed over the years, 6.9% in the overall disease (with no statistical significance). Sepsis/bacteremia was detected in 63.6% of the newborns, meningitis in 32.8%, and arthritis/osteomyelitis in 3.5%. In cases with known obstetrics dates, 53% of mothers had been colonized by GBS during pregnancy, 53.8% received intrapartum antibiotic prophylaxis, and 41.2% had some obstetric risk factors, particularly premature birth in 35.9%. There was a 2.8% mortality rate in the neonates, and predominant serotypes were III and Ia.


CONCLUSIONS
The incidence of GBS late-onset disease has not decreased despite the control practices of early-onset disease, and possibility of this appearing must be taken into account.
Servicio de Microbiología, Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat, Barcelona, España. Electronic address: tjuncosa@hsjdbcn.org.
Teresa
T
Juncosa-Morros
Laboratori Barcelonès Nord i Vallès Oriental, ICS, Badalona, Barcelona, España.
Cèlia
C
Guardià-Llobet
Servicio de Microbiología, Hospital Clínic, Barcelona, España.
Jordi
J
Bosch-Mestres
Laboratori Clínic de l'Hospitalet, Ambulatori Just Oliveras, Hospitalet de Llobregat, Barcelona, España.
Eva
E
Dopico-Ponte
Servicio de Microbiología, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, España.
Isabel
I
Sanfeliu-Sala
Laboratorio de Microbiología, Hospital de Barcelona, Barcelona, España.
Montserrat
M
Sierra-Soler
Servicio de Microbiología, Hospital de Sant Pau, Barcelona, España.
Ferran
F
Sánchez-Reus
Servicio de Microbiología, Hospital Germans Trias i Pujol, Badalona, Barcelona, España.
Montserrat
M
Giménez-Pérez
Laboratorio de Microbiología, Hospital Universitario Mútua de Terrassa, Terrassa, Barcelona, España.
Josep
J
Lite-Lite
Servei de Microbiologia, Hospital Vall d'Hebron, Barcelona, España.
Antònia
A
Andreu-Domingo
D017668:Age of Onset; D019072:Antibiotic Prophylaxis; D001170:Arthritis, Infectious / Q000453:epidemiology / Q000382:microbiology; D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D005260:Female; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000382:microbiology; D016920:Meningitis, Bacterial / Q000453:epidemiology / Q000382:microbiology; D010019:Osteomyelitis / Q000453:epidemiology / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000382:microbiology; D012189:Retrospective Studies; D012306:Risk; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D013290:Streptococcal Infections / Q000151:congenital / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D013292:Streptococcus agalactiae / Q000302:isolation & purification*
Infección neonatal; Late onset neonatal sepsis; Neonatal infection; Sepsis neonatal tardía; Streptococcus agalactiae